Overview
US Stock Market
Technology
Financial
Real Estate
Energy
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Healthcare
Industrials
Utilities
Other Symbols
Currencies
Major
Minor
America
Europe
Asia
Cryptocurrencies
Metals
Indexes
Commodities
Charts
WidgetsTAK: Takeda Pharmaceutical Company Limited American Depositary Share
TAK exchange rate has changed by -0.70% for today. During the day, the instrument was traded at a low of 19.91 and at a high of 20.03.
Follow Takeda Pharmaceutical Company Limited American Depositary Share dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TAK News
- Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push
- Takeda Announces New Data From VERDICT Showing That Treating Adults With Intravenous ENTYVIO To Achieve Corticosteroid-Free Disease Clearance Resulted In Significantly Longer Time To First Ulcerative Colitis-Related Complication, Reducing UC...
- Ascentage Pharma Stock Could More Than Double: Analyst
- Reported Earlier, Takeda Launches ORZEYFUL In Japan And China As First-In-Class Orexin Agonist For Narcolepsy Type 1, With US Launch Set For Next Month After DEA Scheduling
- Takeda Reports TAK-881 Cuts Infusion Volume 50%, Single-Site Infusion Time 42.6% Vs. HyQvia In Phase 2/3 Immunodeficiency Trial
- Takeda Remains A Buy, Boosted By Recent Narcolepsy Drug Approval And Robust Pipeline
- Takeda Presents Phase 3 Data Showing Once-Daily Oral Zasocitinib Delivers Higher PASI 100 At 36.5% Vs 13.9% And PASI 90 At 62.5% Vs 34.0% Than Deucravacitinib At Week 16; Under FDA, EMA Review For Plaque Psoriasis
- KROS Begins Dosing in Phase II Study With Rinvatercept in DMD
- Keros Therapeutics Expects $20M Development Milestone Payment Under Elritercept License Agreement Of With Takeda After Dosing Of First Patient In The ELRiSE MF Clinical Trial
- This Cancer Drug Is Already Working. Now Its Nvidia-Backed Maker Is Going Public: Here’s What You Need to Know About Its IPO
- Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?
- 5 Undervalued Oncology Stocks Wall Street Is Overlooking (NASDAQ:IBB)
- Best Value Stocks to Buy for September 14th
- Best Income Stocks to Buy for September 14th
- Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
- Exelixis: 'Hold' On Zanzalintinib Subpopulation Miss And STELLAR-304 H2 2026 Data
- Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
- Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug - Takeda Pharmaceutical Co (NYSE:TAK)
- Silence Therapeutics: Making Some Recent Noise (NASDAQ:SLN)
- Wall Street Analysts Think Takeda Pharmaceutical Co. (TAK) Could Surge 26.41%: Read This Before Placing a Bet
- Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
- Best Income Stocks to Buy for August 17th
- New Strong Buy Stocks for August 17th
- Can Asceniv Help ADMA Stock Combat IG Market Challenges?
Frequently Asked Questions
What is TAK stock price today?
Takeda Pharmaceutical Company Limited American Depositary Share stock is priced at 19.94 today. It trades within 19.91 - 20.03, yesterday's close was 20.08, and trading volume reached 1824. The live price chart of TAK shows these updates.
Does Takeda Pharmaceutical Company Limited American Depositary Share stock pay dividends?
Takeda Pharmaceutical Company Limited American Depositary Share is currently valued at 19.94. Dividend policy depends on the company, while investors also watch 48.75% and USD. View the chart live to track TAK movements.
How to buy TAK stock?
You can buy Takeda Pharmaceutical Company Limited American Depositary Share shares at the current price of 19.94. Orders are usually placed near 19.94 or 20.24, while 1824 and -0.05% show market activity. Follow TAK updates on the live chart today.
How to invest into TAK stock?
Investing in Takeda Pharmaceutical Company Limited American Depositary Share involves considering the yearly range 13.35 - 20.13 and current price 19.94. Many compare 10.35% and 20.05% before placing orders at 19.94 or 20.24. Explore the TAK price chart live with daily changes.
What are Takeda Pharmaceutical Company Limited American Depositary Share stock highest prices?
The highest price of Takeda Pharmaceutical Company Limited American Depositary Share in the past year was 20.13. Within 13.35 - 20.13, the stock fluctuated notably, and comparing with 20.08 helps spot resistance levels. Track Takeda Pharmaceutical Company Limited American Depositary Share performance using the live chart.
What are Takeda Pharmaceutical Company Limited American Depositary Share stock lowest prices?
The lowest price of Takeda Pharmaceutical Company Limited American Depositary Share (TAK) over the year was 13.35. Comparing it with the current 19.94 and 13.35 - 20.13 shows potential long-term entry points. Watch TAK moves on the chart live for more details.
When did TAK stock split?
Takeda Pharmaceutical Company Limited American Depositary Share has gone through stock splits historically. These changes are visible in , 20.08, and 48.75% after corporate actions.
- Previous Close
- 20.08
- Open
- 19.95
- Bid
- 19.94
- Ask
- 20.24
- Low
- 19.91
- High
- 20.03
- Volume
- 1.824 K
- Daily Change
- -0.70%
- Month Change
- 10.35%
- 6 Months Change
- 20.05%
- Year Change
- 48.75%
- Act
- -3.060 M
- Fcst
- -4.804 M
- Prev
- -8.557 M
- Act
- 0.987 M
- Fcst
- -0.153 M
- Prev
- 1.862 M
- Act
- Fcst
- Prev
- 5.420%